New light-sensitive technology aims to beat restenosis
This article was originally published in Clinica
Executive Summary
CR Bard and QLT PhotoTherapeutics are to collaborate in developing technology to deliver QLT's photosensitive porfimer sodium compound into coronary arteries, in the hope that it will prevent restenosis.